BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 38138149)

  • 21. Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study.
    Deasy AM; Guccione E; Dale AP; Andrews N; Evans CM; Bennett JS; Bratcher HB; Maiden MC; Gorringe AR; Read RC
    Clin Infect Dis; 2015 May; 60(10):1512-20. PubMed ID: 25814628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.
    Marjuki H; Chang HY; Topaz N; Whaley MJ; Vuong J; Chen A; Jenkins LT; Hu F; Schmink S; Retchless AC; Thomas JD; Acosta AM; McNamara LA; Soeters HM; Mbaeyi S; Wang X
    mBio; 2021 May; 12(3):. PubMed ID: 34006659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Genome Sequencing Reveals Within-Host Genetic Changes in Neisseria meningitidis during Invasive Disease.
    Klughammer J; Dittrich M; Blom J; Mitesser V; Vogel U; Frosch M; Goesmann A; Müller T; Schoen C
    PLoS One; 2017; 12(1):e0169892. PubMed ID: 28081260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gauging the epidemic potential of a widely circulating non-invasive meningococcal strain in Africa.
    Brynildsrud OB; Eldholm V; Rakhimova A; Kristiansen PA; Caugant DA
    Microb Genom; 2019 Aug; 5(8):. PubMed ID: 31454306
    [No Abstract]   [Full Text] [Related]  

  • 25. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study.
    Hill DM; Lucidarme J; Gray SJ; Newbold LS; Ure R; Brehony C; Harrison OB; Bray JE; Jolley KA; Bratcher HB; Parkhill J; Tang CM; Borrow R; Maiden MC
    Lancet Infect Dis; 2015 Dec; 15(12):1420-8. PubMed ID: 26515523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18.
    Bentley SD; Vernikos GS; Snyder LA; Churcher C; Arrowsmith C; Chillingworth T; Cronin A; Davis PH; Holroyd NE; Jagels K; Maddison M; Moule S; Rabbinowitsch E; Sharp S; Unwin L; Whitehead S; Quail MA; Achtman M; Barrell B; Saunders NJ; Parkhill J
    PLoS Genet; 2007 Feb; 3(2):e23. PubMed ID: 17305430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmission Dynamics and Microevolution of Neisseria meningitidis During Carriage and Invasive Disease in High School Students in Georgia and Maryland, 2006-2007.
    Mustapha MM; Marsh JW; Shutt KA; Schlackman J; Ezeonwuka C; Farley MM; Stephens DS; Wang X; Van Tyne D; Harrison LH
    J Infect Dis; 2021 Jun; 223(12):2038-2047. PubMed ID: 33107578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt.
    Greenwood BM; Aseffa A; Caugant DA; Diallo K; Kristiansen PA; Maiden MCJ; Stuart JM; Trotter CL
    Trop Med Int Health; 2019 Feb; 24(2):143-154. PubMed ID: 30461138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis.
    McMillan M; Chandrakumar A; Wang HLR; Clarke M; Sullivan TR; Andrews RM; Ramsay M; Marshall HS
    Clin Infect Dis; 2021 Aug; 73(3):e609-e619. PubMed ID: 33212510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 31. Meningococcal carriage and disease--population biology and evolution.
    Caugant DA; Maiden MC
    Vaccine; 2009 Jun; 27 Suppl 2(4):B64-70. PubMed ID: 19464092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.
    Retchless AC; Hu F; Ouédraogo AS; Diarra S; Knipe K; Sheth M; Rowe LA; Sangaré L; Ky Ba A; Ouangraoua S; Batra D; Novak RT; Ouédraogo Traoré R; Wang X
    mSphere; 2016; 1(6):. PubMed ID: 27904879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic.
    Kriz P; Giorgini D; Musilek M; Larribe M; Taha MK
    Res Microbiol; 1999 May; 150(4):273-80. PubMed ID: 10376489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic, Transcriptomic, and Phenotypic Analyses of
    Ren X; Eccles DA; Greig GA; Clapham J; Wheeler NE; Lindgreen S; Gardner PP; MacKichan JK
    mSystems; 2017; 2(6):. PubMed ID: 29152586
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of recombination on the evolution of a population of
    MacAlasdair N; Pesonen M; Brynildsrud O; Eldholm V; Kristiansen PA; Corander J; Caugant DA; Bentley SD
    Genome Res; 2021 Jul; 31(7):1258-1268. PubMed ID: 34108268
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic, Functional, and Immunogenic Analyses of the
    Næss LM; Maugesten IS; Caugant DA; Kassu A; Aseffa A; Børud B
    J Bacteriol; 2023 Mar; 205(3):e0045822. PubMed ID: 36852982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.
    MenAfriCar consortium
    J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of
    Marshall HS; McMillan M; Koehler A; Lawrence A; MacLennan J; Maiden M; Ramsay M; Ladhani SN; Trotter C; Borrow R; Finn A; Sullivan T; Richmond P; Kahler C; Whelan J; Vadivelu K
    BMJ Open; 2019 May; 9(5):e027233. PubMed ID: 31064808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.
    McNeil LK; Zagursky RJ; Lin SL; Murphy E; Zlotnick GW; Hoiseth SK; Jansen KU; Anderson AS
    Microbiol Mol Biol Rev; 2013 Jun; 77(2):234-52. PubMed ID: 23699256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.
    Stephens DS
    Vaccine; 2009 Jun; 27 Suppl 2(Suppl 2):B71-7. PubMed ID: 19477055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.